Proteolytic Balance in Patients with Multiple Sclerosis During Interferon Treatment
Proteolytic Balance in Patients with Multiple Sclerosis During Interferon Treatment
About this item
Full title
Author / Creator
Publisher
United States: Mary Ann Liebert, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Mary Ann Liebert, Inc
Subjects
More information
Scope and Contents
Contents
Multiple sclerosis (MS) is a progressive, inflammatory, demyelinating disease. An altered cytokine network has been reported to occur during the disease, and its pathogenetic role has been hypothesized. To date, interferon-beta (IFN-beta) is the most effective and reliable therapy in the majority of MS patients, although the mechanisms underlying i...
Alternative Titles
Full title
Proteolytic Balance in Patients with Multiple Sclerosis During Interferon Treatment
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_71968355
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_71968355
Other Identifiers
ISSN
1079-9907
E-ISSN
1557-7465
DOI
10.1089/10799900260100187
